[Aluminum and iron deposition in dialysis patients].
Kurihara
S
S
Division of Nephrology, Kasukabe-Shuwa Hospital.
Marumo
F
F
D000535:Aluminum / Q000378:metabolism*; D000740:Anemia / Q000209:etiology; D001851:Bone Diseases, Metabolic / Q000209:etiology*; D003676:Deferoxamine / Q000627:therapeutic use; D004921:Erythropoietin / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007676:Kidney Failure, Chronic / Q000378:metabolism* / Q000628:therapy; D008659:Metabolic Diseases / Q000209:etiology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects*
D011994:Recombinant Proteins; D004921:Erythropoietin; D000535:Aluminum; D007501:Iron; D003676:Deferoxamine